Article info

Download PDFPDF
Commentary to ‘Novel drug candidates targeting Alzheimer’s disease: ethical challenges with identifying the relevant patient population’

Authors

  • Maria Eriksdotter Department of Neurobiology, Karolinska Institutet, Stockholm, Sweden Theme Inflammation and Aging, Karolinska University Hospital, Huddinge, Sweden PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Maria Eriksdotter, Department of Neurobiology, Karolinska Institutet, Stockholm 141 83, Sweden; Maria.Eriksdotter{at}ki.se
View Full Text

Citation

Eriksdotter M
Commentary to ‘Novel drug candidates targeting Alzheimer’s disease: ethical challenges with identifying the relevant patient population’

Publication history

  • Received August 10, 2021
  • Accepted August 10, 2021
  • First published August 20, 2021.
Online issue publication 
August 23, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Other content recommended for you